These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

741 related items for PubMed ID: 18255347

  • 1. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M, Mishra R, Shami VM, Northup PG, Berg CL, Bashlor P, Jones P, Ellen K, Weiss GR, Brenin CM, Kurth BE, Rich TA, Adams RB, Yeaton P.
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [Abstract] [Full Text] [Related]

  • 2. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
    Fuks D, Bartoli E, Delcenserie R, Yzet T, Celice P, Sabbagh C, Chatelain D, Joly JP, Cheron N, Dupas JL, Regimbeau JM.
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
    [Abstract] [Full Text] [Related]

  • 3. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS, Cosgrove ND, Patrie JT, Cox DG, Bauer TW, Adams RB, Mann JA, Sauer BG, Shami VM, Wang AY.
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment.
    Talreja JP, DeGaetani M, Sauer BG, Kahaleh M.
    Photochem Photobiol Sci; 2011 Jul; 10(7):1233-8. PubMed ID: 21512706
    [Abstract] [Full Text] [Related]

  • 5. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
    Harewood GC, Baron TH, Rumalla A, Wang KK, Gores GJ, Stadheim LM, de Groen PC.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):415-20. PubMed ID: 15740486
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy for cholangiocarcinoma.
    Berr F.
    Semin Liver Dis; 2004 May; 24(2):177-87. PubMed ID: 15192790
    [Abstract] [Full Text] [Related]

  • 7. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
    Paik WH, Park YS, Hwang JH, Lee SH, Yoon CJ, Kang SG, Lee JK, Ryu JK, Kim YT, Yoon YB.
    Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
    [Abstract] [Full Text] [Related]

  • 8. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
    Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M.
    Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
    [Abstract] [Full Text] [Related]

  • 9. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC, Tang ZY, Fan J, Zhou J, Qin LX, Ye SL, Sun HC, Wang BL, Li D, Wang JH, Zeng MS, Guo W, Tan YS.
    Cancer J; 2006 Aug; 12(2):113-22. PubMed ID: 16630402
    [Abstract] [Full Text] [Related]

  • 10. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.
    Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF.
    Am J Gastroenterol; 2005 Nov; 100(11):2426-30. PubMed ID: 16279895
    [Abstract] [Full Text] [Related]

  • 11. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE, Stein DE, Eschelman DJ, Topham AK, Waterman FM, Rosato EL, Alden M, Anne PR.
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [Abstract] [Full Text] [Related]

  • 12. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video).
    Kim JY, Kang DH, Kim HW, Choi CW, Kim ID, Hwang JH, Kim DU, Eum JS, Bae YM.
    Gastrointest Endosc; 2009 Dec; 70(6):1109-15. PubMed ID: 19647244
    [Abstract] [Full Text] [Related]

  • 14. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
    Válek V, Kysela P, Kala Z, Kiss I, Tomásek J, Petera J.
    Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M, Caca K, Berr F, Schiefke I, Tannapfel A, Wittekind C, Mössner J, Hauss J, Witzigmann H.
    Cancer; 2003 Jun 01; 97(11):2783-90. PubMed ID: 12767091
    [Abstract] [Full Text] [Related]

  • 16. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM, Frühauf NR, Lang H, Sauerwein W, Sotiropoulos GC, Zöpf T, Grabellus F, Wittig A, Oldhafer KJ, Malagó M, Broelsch CE.
    Hepatogastroenterology; 2008 Jun 01; 55(88):1951-4. PubMed ID: 19260456
    [Abstract] [Full Text] [Related]

  • 17. Palliation for suspected unresectable hilar cholangiocarcinoma.
    Connor S, Barron E, Redhead DN, Ireland H, Madhavan KK, Parks RW, Garden OJ.
    Eur J Surg Oncol; 2007 Apr 01; 33(3):341-5. PubMed ID: 17175127
    [Abstract] [Full Text] [Related]

  • 18. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.
    Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J, Lochs H.
    Gastroenterology; 2003 Nov 01; 125(5):1355-63. PubMed ID: 14598251
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
    Prasad GA, Wang KK, Baron TH, Buttar NS, Wongkeesong LM, Roberts LR, LeRoy AJ, Lutzke LS, Borkenhagen LS.
    Clin Gastroenterol Hepatol; 2007 Jun 01; 5(6):743-8. PubMed ID: 17545000
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy in cholangiocarcinomas.
    Ortner MA.
    Best Pract Res Clin Gastroenterol; 2004 Feb 01; 18(1):147-54. PubMed ID: 15123089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.